CDXS

NASD Codexis, Inc.

Sep 29, 2026 · 7:57 PM ET LAST TRADE Market Closed

$1.35 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.35, $0.04 below the day’s high of $1.39

YTD change: -17.18%
vs 20-day SMA: -5.03%
vs 200-day SMA: -27.40%

Price ranges

Previous day

$1.31 $1.39

open $1.31 close $1.36

+$0.05 (+3.82%)

Today

$1.35 $1.39

open $1.36 now $1.35

-$0.01 (-0.74%)

Past week

$1.31 $1.43

from $1.38 now $1.35

-$0.03 (-2.17%)

Past month

$1.27 $1.72

from $1.59 now $1.35

-$0.24 (-15.09%)

This year

$0.96 $2.98

from $1.63 now $1.35

-$0.28 (-17.18%)

Price & Performance

-0.16 (-10.53%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 96.8% away from all-time highs of $42.01
CDXS is down 17% since the beginning of the year
CDXS is down 45% over the past 12 months
CDXS is down 15% over the past 1 month
4% of all CDXS investors are betting against CDXS

CDXS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -44.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.13

Earnings momentum -35.8% Quarterly EPS growth

Quarterly change -35.8%

Valuation

P/E ratio N/A

Enterprise value $141.1M

Beta 3.22

Balance sheet & scale

IncomeN/A

Revenue$77.7M

Cash$55.3M

Debt$72.6K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $147.8M

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Competitor comparison

Ticker	Company	Price	Change
REGN	Regeneron Pharmaceuticals, Inc.	$752.25	-4.54%
IQV	IQVIA Holdings Inc	$270.97	+0.22%
CRL	Charles River Laboratories International, Inc.	$294.59	+0.60%
ICLR	ICON Plc	$175.57	+1.88%
MDGL	Madrigal Pharmaceuticals, Inc.	$517.04	+0.09%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.